Commentary
F. Tremolieres*
Abstract
During the first six months of the Covid-19 outbreak, nearly 2,000 clinical trials involving drugs were registered. Who has ever seen in the past, in so short time, such a rush to drug trials for the same disease? Who has ever seen such a prompt media broadcast of any trial, whether it shows any preliminary results, positive or not? Worse! Any announcement of a product that is supposed to do something is immediately promoted, and we push for trials to start "subito" as our Italian friends say. We remember what happened with nicotine, chlorpromazine, ivermectin and so many others, not forgetting various Chinese plants.